Hu3F8-BsAb
Hu3F8-BsAb Uses, Dosage, Side Effects, Food Interaction and all others data.
Hu3F8-BsAb is under investigation in clinical trial NCT03860207 (Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3f8-bsab) in Patients With Relapsed/refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers).
| Trade Name | Hu3F8-BsAb |
| Generic | Nivatrotamab |
| Nivatrotamab Other Names | Hu3F8-BsAb, Nivatrotamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Hu3F8-BsAb
